Skip to content

Nighttime Feeding and Morning Endurance Performance

Effect of Nighttime Feeding on Morning Performance in Female Endurance Athletes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02160873
Enrollment
12
Registered
2014-06-11
Start date
2014-06-30
Completion date
2015-04-30
Last updated
2017-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor Performance Status

Brief summary

The purpose of this study is to investigate the influence of a nighttime feeding on next morning running performance, hydration status, and exercise metabolism in female endurance athletes. Specifically, the effect of a chocolate milk beverage will be examined versus a non-nutritive, flavor-matched placebo. The investigators hypothesize that the nighttime consumption of chocolate milk, a whole food complex, will result in improved next morning running performance versus placebo. Secondarily, the investigators hypothesize that any potential positive performance outcomes from the chocolate milk treatment may be due to an enhanced pre-exercise hydration status or improved exercise metabolism.

Detailed description

This study will be interventional in nature and employ a crossover, randomized, double-blinded approach. This study will include a maximal oxygen uptake test and three trials: one familiarization trial, and two experimental trials. The familiarization will serve as a practice test to minimize any training effects between experimental trials. The experimental trials will be completed within a 2-week period determined by the luteal phase of the menstrual cycle (days 15-28 of the menstrual cycle, with day 1 being the first day of menstruation). A minimum of 48-72 hours will be provided between testing days. Experimental trials will consist of baseline testing (height, weight, urinalysis, resting metabolic rate), followed by a treadmill performance protocol. Participants will complete a 3-stage incremental exercise test (at 55%, 65%, and 75% of maximal oxygen uptake respectively). Metabolic data will be collected during this time. Participants will then complete a 10-kilometer running time trial in which markers of intensity are monitored at various time points (blood glucose, blood lactate, heart rate, rating of perceived exertion). Participants and primary researchers will be blinded to all time and speed data. Distance will be the only known measure of progress. Additional blood, urine, and body weight measures will be taken immediately post exercise.

Interventions

12 oz, 7-8 hours prior to exercise trial (night before)

OTHERflavor-matched placebo

12 oz, non-caloric flavor-matched placebo

Sponsors

Florida State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Female * Between the ages of 18 and 40 years old * Consistently use oral contraceptives (greater than 2 months) or be considered eumenorrheic without oral contraceptive use * 'Moderately trained,' defined as a weekly mileage ≥ 25 miles for at least 6 months, and a VO2max ≥ 45 ml/kg/min

Exclusion criteria

* Lactose intolerant * Smokers * Uncontrolled thyroid conditions * Uses anti-inflammatory drugs or any dietary supplements intended to improve performance * Have musculoskeletal injury that could limit performance

Design outcomes

Primary

MeasureTime frameDescription
Running Performance24 hours10K time trial on a treadmill

Secondary

MeasureTime frameDescription
Urine Specific Gravity24 hoursChanges in urine specific gravity will be measured pre and post a 10K time trial run on a treadmill
Urine Volume24 hourMeasurement of total urine output.

Other

MeasureTime frameDescription
Exercise Metabolism24 hoursIndirect calorimetry will be used to assess macronutrient use during exercise via the respiratory exchange ratio

Countries

United States

Participant flow

Recruitment details

12 subjects were recruited from the Tallahassee running community.

Pre-assignment details

Subjects were randomized to receive either chocolate milk first or placebo first. In between exercise trials, there was a 7-day washout period.

Participants by arm

ArmCount
Chocolate Milk First, Then Placebo
chocolate milk: 12 oz, 7-8 hours prior to exercise trial (night before) followed by a 7-day washout, then placebo 7-8 hours prior to exercise trial.
6
Flavor-matched Placebo, Then Chocolate Milk
flavor-matched placebo: 12 oz, 7-8 hours prior to exercise trial (night before) followed by a 7-day washout, then chocolate milk 7-8 hours prior to exercise trial.
6
Total12

Baseline characteristics

CharacteristicFlavor-matched Placebo, Then Chocolate MilkTotalChocolate Milk First, Then Placebo
Age, Continuous29.3 years
STANDARD_DEVIATION 7.1
29.8 years
STANDARD_DEVIATION 6.5
30.3 years
STANDARD_DEVIATION 6.4
Body fat (%)22.1 %
STANDARD_DEVIATION 5
21.8 %
STANDARD_DEVIATION 5.1
21.4 %
STANDARD_DEVIATION 5.7
Maximal oxygen consumption (ml/kg/min)53.8 ml/kg/min
STANDARD_DEVIATION 4.5
52.8 ml/kg/min
STANDARD_DEVIATION 4.2
51.8 ml/kg/min
STANDARD_DEVIATION 4.1
Region of Enrollment
United States
6 participants12 participants6 participants
Sex: Female, Male
Female
6 Participants12 Participants6 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
4 / 120 / 12
serious
Total, serious adverse events
0 / 120 / 12

Outcome results

Primary

Running Performance

10K time trial on a treadmill

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
Chocolate MilkRunning Performance52.8 minutesStandard Deviation 8
Flavor-matched PlaceboRunning Performance52.8 minutesStandard Deviation 8.4
Secondary

Urine Specific Gravity

Changes in urine specific gravity will be measured pre and post a 10K time trial run on a treadmill

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
Chocolate MilkUrine Specific Gravity-0.005 Urine specific gravityStandard Deviation 0.008
Flavor-matched PlaceboUrine Specific Gravity-0.002 Urine specific gravityStandard Deviation 0.009
Secondary

Urine Volume

Measurement of total urine output.

Time frame: 24 hour

ArmMeasureValue (MEAN)Dispersion
Chocolate MilkUrine Volume718.07 mililitersStandard Deviation 260.82
Flavor-matched PlaceboUrine Volume874.82 mililitersStandard Deviation 179.6
Other Pre-specified

Exercise Metabolism

Indirect calorimetry will be used to assess macronutrient use during exercise via the respiratory exchange ratio

Time frame: 24 hours

ArmMeasureGroupValue (MEAN)Dispersion
Chocolate MilkExercise Metabolism55% VO2max0.84 Respiratory exchange ratioStandard Deviation 0.04
Chocolate MilkExercise Metabolism65% VO2max0.85 Respiratory exchange ratioStandard Deviation 0.04
Chocolate MilkExercise Metabolism75% VO2max0.87 Respiratory exchange ratioStandard Deviation 0.03
Flavor-matched PlaceboExercise Metabolism55% VO2max0.82 Respiratory exchange ratioStandard Deviation 0.04
Flavor-matched PlaceboExercise Metabolism65% VO2max0.83 Respiratory exchange ratioStandard Deviation 0.03
Flavor-matched PlaceboExercise Metabolism75% VO2max0.85 Respiratory exchange ratioStandard Deviation 0.03

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026